menu search

NVTA / 3 Things About Invitae Every Smart Investor Knows

3 Things About Invitae Every Smart Investor Knows
Invitae's stock is down and it might get delisted from its stock exchange. It has a new crop of top managers, but it's running low on cash. Read More
Posted: Nov 4 2023, 09:59
Author Name: The Motley Fool
Views: 052144

NVTA News  

3 Things About Invitae Every Smart Investor Knows

By The Motley Fool
November 4, 2023

3 Things About Invitae Every Smart Investor Knows

Invitae's stock is down and it might get delisted from its stock exchange. It has a new crop of top managers, but it's running low on cash. more_horizontal

Is Invitae Stock a Buy Now?

By The Motley Fool
November 1, 2023

Is Invitae Stock a Buy Now?

Invitae's revenue has climbed over time thanks to a vast portfolio of genetic tests. At the same time, the company has struggled to turn that into pro more_horizontal

Why Invitae Stock Popped Today

By The Motley Fool
October 2, 2023

Why Invitae Stock Popped Today

Late Friday, the U.S. FDA granted De Novo marketing authorization for the Invitae Common Hereditary Cancers Panel. The panel is the first of its kind more_horizontal

Why Is Invitae (NVTA) Stock Up 28% Today?

By InvestorPlace
October 2, 2023

Why Is Invitae (NVTA) Stock Up 28% Today?

Invitae (NYSE: NVTA ) stock is on the rise Monday despite a lack of news from the medical genetics company this morning. There haven't been any new pr more_horizontal

Cathie Wood Is Betting on This Struggling Stock. Should You?

By The Motley Fool
September 14, 2023

Cathie Wood Is Betting on This Struggling Stock. Should You?

Invitae has struggled to turn rising revenue into profit. Last year, the company launched a strategic plan to pave the way to positive cash flow and i more_horizontal

Down 97%, Is It Finally Time to Buy Invitae Stock?

By The Motley Fool
July 26, 2023

Down 97%, Is It Finally Time to Buy Invitae Stock?

Stock market analysts have conflicting opinions about the market value of this genetic testing business. Worth more than $10 billion at its peak, beat more_horizontal

Invitae (NVTA) Upgraded to Buy: Here's Why

By Zacks Investment Research
July 21, 2023

Invitae (NVTA) Upgraded to Buy: Here's Why

Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

Down 98% Is This Cathie Wood Stock a Screaming Buy?

By The Motley Fool
July 12, 2023

Down 98% Is This Cathie Wood Stock a Screaming Buy?

Popular investment manager Cathie Wood is known for investing in innovative growth stocks. more_horizontal


Search within

Pages Search Results: